Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

NCT04470024 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Cancer of the Head and Neck

Interventions

DRUG: INCAGN01876
DRUG: INCMGA00012
BIOLOGICAL: DPV-001

Sponsor

Providence Health & Services